Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan C Grutters

Showing results (181-190 of 219) with videos related to

Pageof 22
Sort By:
JACC. Cardiovascular Imaging|June 4, 2025
Global Practices in Cardiac Imaging for Cardiac Sarcoidosis: A Survey Study of International Experts With Delphi ConsensusTahir S Kafil, Manuel L Ribeiro Neto, Marc A Judson, et al.
Human Molecular Genetics|August 6, 2010
Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groupsHiroe Sato, Felix A Woodhead, Tariq Ahmad, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 4, 2012
Addition of vitamin D status to prognostic scores improves the prediction of outcome in community-acquired pneumoniaHilde H F Remmelts, Ewoudt M W van de Garde, Sabine C A Meijvis, et al.
Annals of the American Thoracic Society|September 24, 2020
Evaluating the Minimal Clinically Important Difference of the King's Sarcoidosis Questionnaire in a Multicenter Prospective StudyRobert P Baughman, Marc A Judson, Jennifer L Beaumont, et al.
Targeted Oncology|July 21, 2019
Prospective Study of Drug-induced Interstitial Lung Disease in Advanced Breast Cancer Patients Receiving Everolimus Plus ExemestaneAnnelieke E C A B Willemsen, Jolien Tol, Nielka P van Erp, et al.
The Lancet. Respiratory Medicine|November 9, 2025
A paradigm shift in corticosteroid therapy for sarcoidosis: a World Association of Sarcoidosis and Other Granulomatous Disorders Position Paper, endorsed by the Americas Association of Sarcoidosis and Other Granulomatous DisordersAthol U Wells, Elyse E Lower, Robert P Baughman, et al.
The European Respiratory Journal|December 22, 2022
European Respiratory Society statement on familial pulmonary fibrosisRaphael Borie, Caroline Kannengiesser, Katerina Antoniou, et al.
BMJ Open Respiratory Research|April 9, 2019
First patient-centred set of outcomes for pulmonary sarcoidosis: a multicentre initiativeNynke A Kampstra, Jan C Grutters, Frouke T van Beek, et al.
The European Respiratory Journal|January 15, 2021
Adjunctive treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired pneumonia: a randomised clinical trialEsther Wittermans, Stefan M T Vestjens, Simone M C Spoorenberg, et al.
American Journal of Respiratory and Critical Care Medicine|July 27, 2010
Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a dutch cohortColine H M van Moorsel, Matthijs F M van Oosterhout, Nicole P Barlo, et al.
Pageof 22

Showing results (181-190 of 219) with videos related to

Sort By:
Pageof 22
JACC. Cardiovascular Imaging|June 4, 2025
Global Practices in Cardiac Imaging for Cardiac Sarcoidosis: A Survey Study of International Experts With Delphi ConsensusTahir S Kafil, Manuel L Ribeiro Neto, Marc A Judson, et al.
Human Molecular Genetics|August 6, 2010
Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groupsHiroe Sato, Felix A Woodhead, Tariq Ahmad, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 4, 2012
Addition of vitamin D status to prognostic scores improves the prediction of outcome in community-acquired pneumoniaHilde H F Remmelts, Ewoudt M W van de Garde, Sabine C A Meijvis, et al.
Annals of the American Thoracic Society|September 24, 2020
Evaluating the Minimal Clinically Important Difference of the King's Sarcoidosis Questionnaire in a Multicenter Prospective StudyRobert P Baughman, Marc A Judson, Jennifer L Beaumont, et al.
Targeted Oncology|July 21, 2019
Prospective Study of Drug-induced Interstitial Lung Disease in Advanced Breast Cancer Patients Receiving Everolimus Plus ExemestaneAnnelieke E C A B Willemsen, Jolien Tol, Nielka P van Erp, et al.
The Lancet. Respiratory Medicine|November 9, 2025
A paradigm shift in corticosteroid therapy for sarcoidosis: a World Association of Sarcoidosis and Other Granulomatous Disorders Position Paper, endorsed by the Americas Association of Sarcoidosis and Other Granulomatous DisordersAthol U Wells, Elyse E Lower, Robert P Baughman, et al.
The European Respiratory Journal|December 22, 2022
European Respiratory Society statement on familial pulmonary fibrosisRaphael Borie, Caroline Kannengiesser, Katerina Antoniou, et al.
BMJ Open Respiratory Research|April 9, 2019
First patient-centred set of outcomes for pulmonary sarcoidosis: a multicentre initiativeNynke A Kampstra, Jan C Grutters, Frouke T van Beek, et al.
The European Respiratory Journal|January 15, 2021
Adjunctive treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired pneumonia: a randomised clinical trialEsther Wittermans, Stefan M T Vestjens, Simone M C Spoorenberg, et al.
American Journal of Respiratory and Critical Care Medicine|July 27, 2010
Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a dutch cohortColine H M van Moorsel, Matthijs F M van Oosterhout, Nicole P Barlo, et al.
Pageof 22